85% of north-eastern districts in front runner category in North-Eastern Region District SDG Index 2023-24: NITI Aayog
District SDG Index
for 2023-24.
The second edition of the index, released by
NITI Aayog
, on Monday shows an overall increase in the proportion of districts in the front runner category to 85% from 62% in the last edition. However, not a single district is in the achievers category.
'This signifies the impact of the national flagship schemes coupled with the localisation efforts of the states and saturation of benefits through initiatives like the Aspirational Districts Programme,' the Aayog said in the report.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Villas For Sale in Dubai Might Surprise You
Villas in Dubai | Search Ads
Get Info
Undo
Significant improvements have been observed in the indicators linked to the National Family Health Survey (NFHS) in sectors such as access to clean cooking fuel, housing, electricity, sanitation, drinking water, bank accounts, child and maternal health services, schooling and attendance, birth registration, unmet need for family planning, health insurance, among others.
'This momentum will be key to closing the gap with the national average in the short and medium term and for states to feature among the top states in the long term,' the Aayog said.
Live Events
In this context, indicator level analysis is crucial for identifying gaps and accelerating progress in the short term and beyond. It would also help in addressing intra-regional and inter-district disparities to ensure that performance is in line with or above the national average.
The index, developed by the Aayog collaboratively with the ministry of development of north eastern region, state governments of the north eastern region and UNDP India, covers 15 SDGs and ranks 121 of 131 districts of the region compared to 105 districts compared in the previous edition released in 2021.
As per the index, Nagaland exhibited the widest range (15.07 points between its highest and lowest performing districts) indicating the significant intra-state disparity while Sikkim has the narrowest range (5.5 points), showing the most consistent performance across its districts.
On the other hand, Tripura has the distinction of having some of the highest-scoring districts with minimum intra-state disparities (6.5 points) while Mizoram and Nagaland have some of the highest-scoring districts but also show significant intra-state variation (ranges of 13.72 and 15.07, respectively).
With less than five years remaining to achieve the Sustainable Development Goals (SDGs), expediting focused efforts to ensure inclusive development for all is imperative, the Aayog cautioned.
As per the report, the Aayog proposes to institutionalise SDGs in the north-eastern states through the whole of government approach, investment in data infrastructure and capacities, integrating
SDG
targets into government budget and recognising the role of partnership, including South-South cooperation as a key strategy to accelerate SDG progress.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
16 minutes ago
- News18
NITI Aayog Calls For Quality Overhaul In Pharma, Industry Flags Challenges
Last Updated: Concerns raised included the increasing number of Not of Standard Quality drug alerts, workforce issues and unsustainable drug pricing policies In a high-level consultation led by NITI Aayog on Monday, leading pharmaceutical industry bodies raised pressing concerns over drug quality, regulatory enforcement, and systemic gaps in technical manpower and infrastructure. The meeting, chaired by Dr VK Paul (Member, Health), was aimed at aligning India's pharmaceutical standards with global benchmarks. Held at NITI Aayog headquarters, the central focus was to assess the challenges hampering the production of high-quality, globally acceptable pharmaceutical products, and to chart a strategy for reform. The Niti Aayog, in its invite, mentioned that it aims to discuss the challenges in producing high-quality medicines while also upholding the title of pharmacy to the world. 'A rigorous focus on quality is also essential to ensure patient safety and trust in public health in the domestic market. With a strong network of over 3,000 pharmaceutical companies and approximately 10,500 manufacturing units across the country, it is essential to invest in and uphold the highest quality standards for pharmaceuticals," highlighted the letter sent to various industry associations, including Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers' Association (IDMA), Laghu Udyog Bharati, Bulk Drug Manufacturers Association (India), Organisation of Pharmaceutical Producers of India (OPPI), Federation of Pharma Entrepreneurs (FOPE) among others. Industry Flags NSQ and Workforce Issues One of the dominant concerns raised was the increasing number of Not of Standard Quality (NSQ) drug alerts. Industry representatives pointed to poor educational standards in pharmacy colleges, which, they said, result in technically under-qualified personnel who are unable to handle the drug inspectors coming for audit. 'The industry highlighted that the gap in technical competence is directly impacting manufacturing quality," an industry official told News18, requesting anonymity. Representatives from the Confederation of Indian Pharmaceutical Industry (CIPI) highlighted the structural and financial constraints faced by MSMEs, especially in conducting stability studies, a critical requirement for ensuring drug quality. They urged the government to provide financial support for MSMEs to build necessary infrastructure, arguing that this could significantly reduce NSQ cases. The industry also advocated for exclusive engagement meetings between policymakers and MSME associations to address deep-rooted, sector-specific issues that are often overlooked in broader policy discussions. In a strong counter-point, RSS-led Laghu Udyog Bharati challenged the narrative that MSMEs are primarily responsible for quality failures. 'US FDA failure by large corporations is generally overlooked in India and small deviations by micro, small and medium enterprises (MSMEs) are given more attention. This has created a bad image of the MSME industry. Big pharma companies are facing product recalls on a regular basis but no one talks about them," Dr Rajesh Gupta, who represents Laghu Udyog Bharati and supports MSME industry, said. 'The myth of 'Brand Bharat' created by large corporations ignores the fact that MSMEs manufacture and sell 97.3 per cent of India's drugs. Yet, only 2.64 per cent are NSQ-declared, and often with no reported harm to patients," Gupta told Newa18, mentioning that he presented the same argument before the government officials in the meeting. Drug Pricing Pressures: Quality vs Affordability Concerns were also raised around the unsustainable drug pricing policies of the price watchdog, National Pharmaceutical Pricing Authority. Industry participants cautioned the government that low price ceilings have made it unviable for manufacturers to produce quality formulations. As an example, they cited cotrimoxazole, an essential antibiotic, which has reportedly vanished from the domestic market due to pricing stress. 'Government wants us to upgrade quality standards and we will do that. But that comes at a cost. We are investing in technology as well as a skilled workforce. While investments are increasing, we are not allowed to increase prices of products. Hence, we are being pushed to discontinue products," said an industry official part of the meeting. Regulator's Firm Stand on GMP and Accountability Drug Controller General of India Dr Rajeev Singh Raghuvanshi, as per industry sources who were part of the meeting, gave a clear message to the industry, saying: 'There will be no relaxation in enforcement of GMP (Good Manufacturing Practices)." 'Emphasising accountability, he outlined a stricter protocol for handling NSQ cases—companies would now face license suspension after a two-week show-cause notice—with reinstatement only upon satisfactory Corrective and Preventive Action (CAPA) review," said the official quoted above. 'He also expressed disappointment with the role of pharma manufacturing associations, urging them to take more responsibility in ensuring that member units uphold quality norms." top videos View all In the ongoing debate between Indian Pharmacopoeia (IP) and WHO-GMP, the DCGI clarified that the two should be seen as parallel and non-conflicting systems. Overall, Gupta and other industry representatives who attended the meeting told News18 that senior government officials, including DCGI and Dr Paul listened attentively to their concerns. The officials were described as patient and receptive, urging the industry to submit their queries in writing for further consideration. 'Everyone was considerate and gave us ample time to present our concerns," Gupta from LBU said. tags : niti aayog pharma sector VK Paul Location : New Delhi, India, India First Published: July 08, 2025, 10:06 IST News india NITI Aayog Calls For Quality Overhaul In Pharma, Industry Flags Challenges
Time of India
31 minutes ago
- Time of India
How food as medicine is transforming senior health in India
'Aging isn't the problem. The assumptions around it are.' India is often described as a young country. And if you look at the stats, we are. But this narrative has, over time, become a kind of tunnel vision. It's visible everywhere: in advertising, in health conversations, and in the cultural obsession with youth. We speak often of energy, ambition, and transformation. But rarely in the context of the one demographic that perhaps needs it the most: our seniors. As per data from multiple sources, more than 140 million Indians are over the age of 60 today. By 2050, that number will double. And yet, mainstream health conversations continue to overlook them. At best, it offers generic advice. At worst, it positions aging as a decline to be fought, rather than a stage to be understood. At the heart of this gap lies a profound opportunity. One we've seen come to life again and again in practice: the power of food. Rewriting the Aging Script After working with hundreds of older adults in India, here's what we've seen firsthand: the body continues to respond, often remarkably well, when its changing needs are met with the right kind of support. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Monte-escalier : dernières aides disponibles en 2025 Confort Escalier Undo These needs aren't complicated. They're just different. And they begin at the most basic, daily level: the food on our plate. Contrary to popular belief, aging doesn't automatically mean illness. But it does mean physiological shifts such as slower digestion, reduced muscle mass, changes in blood sugar metabolism, and altered neurotransmitter function. When we understand these shifts, and adapt food accordingly, something powerful happens: discomfort reduces. Energy improves. Strength returns. This isn't theory. It's real-life feedback from active seniors (people in their 50s and 60s) who tried small, intentional changes. Like replacing raw salads with warm, well-cooked vegetables tempered with ajwain or hing. Or ensuring protein isn't just an afterthought, but present in every major meal. You can simply have moong dal with curd, almond flour roti with hemp chutney, or egg cheela with a sesame laddoo. A Closer Look at What Changes—and What Helps Food isn't just fuel. It's care, especially at this stage of life stage. Digestion slows, but nutrient needs rise. Stomach acid and enzyme levels decline with age, especially impacting protein absorption. Fermented foods like kanji or chaas, gentle spices, and warm, cooked meals make digestion easier and absorption stronger. Muscle loss can be avoided, if we eat for it. Muscle begins to decline in our 40s, but it's only in our 60s that it becomes visibly limiting. Regular movement paired with timely protein (within an hour) can slow or even reverse this trend. Blood sugar becomes more sensitive. Even without a diabetes diagnosis, seniors may notice post-meal spikes. Solutions? More vegetables, fewer refined carbs, a spoon of flaxseed powder, and not skipping meals. Brain fog isn't just 'age.' It's often linked to low neurotransmitter activity and a lack of healthy fats. Foods like sesame, walnuts, ghee, and traditional seeds nourish both brain and body. Gut health becomes central. With nearly 90% of serotonin produced in the gut, digestion affects not just energy and appetite, but also mood. Prebiotic-rich staples like poha, bajra roti, and fermented drinks help maintain microbial balance. What Food as Medicine Actually Means This is not about supplements or expensive products. Nor is it about giving up beloved foods. It's about small, strategic shifts in how we eat. Guided by physiology, not fear. We don't need a separate cuisine for seniors. We need familiar foods, prepared with greater intention. We at Meru Life are building systems that support, not just advise. The idea is to place this scattered knowledge (through generations, regions, and anecdotal wisdom), into the hands of active seniors. But beyond Meru, the conversation itself must grow. Public health programmes, caregiving frameworks, and community kitchens need to recognise this pivotal truth: that food is not a soft topic. It's infrastructure. And when it's done well, it reduces illness, improves independence, and adds years of life lived well. Finally, Five Gentle Rules to Age With Strength Eat warm, well-cooked meals that are easy to digest. Prioritise protein at every major meal. Fill half your plate with cooked vegetables. Embrace traditional fats like ghee, gond, and sesame. Support your gut daily with foods like poha, kanji, and chaas. These aren't diet rules. They're shifts that honour how the body evolves with time. When food meets the body where it is, aging doesn't feel like decline. It feels like rhythm. Like resilience. Like renewal. Co-authored by: Khushboo Jain Tibrewala, functional nutritionist & SME at Meru Life. Mihir Karkare, co-founder & CEO of Meru Life. Common Food Allergies In Children
Time of India
2 hours ago
- Time of India
Common bacterial infection with no symptoms could be the reason behind millions of stomach cancer cases, study warns
A common bacteria found in the stomach could be fuelling millions of stomach cancer cases globally. A new study suggests this bacterial infection could cause nearly 12 million cancers among people born over a single decade. Scientists from the International Agency for Research on Cancer (IARC), part of the World Health Organisation, project that if current trends continue, around 15.6 million people born between 2008 and 2017 will be diagnosed with stomach (gastric) cancer in their lifetime. Of all those cases – 76%, i.e., a staggering 11.9 million, may be caused by the Helicobacter pylori bacteria (H. pylori), according to a study published in the journal Nature Medicine . Read on to know more. What is H. pylori? Stomach cancer, often called a 'silent killer,' is grabbing global attention following the striking new warning – thanks to the world's most under-the-radar risk. Helicobacter pylori, previously known as Campylobacter pylori, is a gram-negative, flagellated, helical bacterium. Mutants can have a rod or curved rod shape that exhibits less virulence. This easily transmissible bacterium often shows no symptoms – which makes it more invincible. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Let's explore more. A common but concealed inhabitant: Half the world's population hosts H. pylori in their stomach lining, often without visible symptoms. It's classified as a class I carcinogen by IARC and the US Carcinogens Report. Transmission vectors: The bacterium spreads through contaminated food or water and close contact, like saliva or fecal-oral routes. It's more prevalent in regions with poor sanitation and crowded living conditions, especially in Asia, Africa, and parts of Latin America. Silent but damaging: Though only 10–20% may show mild symptoms like indigestion or bloating, H. pylori quietly triggers chronic inflammation – setting the stage for ulcers, atrophic gastritis, and eventually cancer. What does the study underline? For the study, scientists examined the incidence of stomach cancer in 185 countries in 2022 and combined it with projections of future deaths. They looked at the potential impact of screen-and-treat strategies for H. pylori and found the number of stomach cancers could be cut by up to 75% overall. Asia accounts for two-thirds of projected future cases, with 10.6 million cases (68% of the total), followed by the Americas (2 million or 13%), Africa (1.7 million or 11%), Europe (1.2 million or 8%), and Oceania (0.07 million or 0.4%). The study projected that under current trends, 11.9 million people could be diagnosed with stomach cancer attributable to H. pylori infection by 2101, which is the year someone born in 2017 would turn 84. Dr. Jin Young Park, one of the study's co-authors and head of the gastric cancer prevention team at the WHO's International Agency for Research on Cancer (IARC), said: 'It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it by planning pilot and feasibility projects, including H. pylori screen-and-treat programmes,' adding, 'With demographic changes set to increase the gastric cancer burden in many parts of the world, there is an urgent need for coordinated prevention strategies and for regional health systems to be prepared to manage the growing burden. ' H. pylori and stomach cancer: A deadly connection Stomach cancer is largely preventable, but the prognosis is poor once a patient is diagnosed. It is the fifth most common form of cancer worldwide, killing an estimated 770,000 people per year. As per the study, chronic infection with H. pylori is a major cause, and it helps explain the rise in stomach cancers among young people in recent years. The link between H. pylori and gastric adenocarcinoma is solid: infected individuals have a 2–6-fold greater risk. According to research , around 90% of stomach cancers are linked to this infection, and up to 89% of non-cardia gastric cancers may be due to H. pylori. Its presence is also tied to MALT lymphoma, with tumor regression observed after eradication. But how does a bug become a carcinogen? The bacterium's virulence, especially strains containing the cagA gene and the cag pathogenicity island, intensifies inflammation and damages DNA repair mechanisms. Persistent inflammation produces reactive oxygen and nitrogen species, leading to DNA damage in gastric cells. Genetic susceptibility and co-factors: Not all infected individuals develop cancer. A study showed that certain genetic variants prompt immune-suppressive environments via IFNα, increasing cancer risk. Environmental risk factors – smoking, high salt intake, low fruit/vegetable diets, obesity, and genetic predispositions – can aggravate the damage. What is stomach cancer? Gastric cancer, also known as stomach cancer, is a disease where malignant (cancerous) cells form in the lining of the stomach. It's a growth of cells that starts in the stomach, a muscular, sac-like organ in the upper abdomen that plays a key role in digesting food. Most stomach cancers are adenocarcinomas, which develop from the gland cells in the stomach's inner lining. While stomach cancer rates have declined in many parts of the world, it's still a significant health concern, particularly in East Asia. Symptoms: Early-stage stomach cancer often doesn't cause noticeable symptoms, but later stages can include pain or discomfort in the upper abdomen, heartburn, feeling full after small meals, nausea, vomiting, and weight loss. Risk Factors: Risk factors include Helicobacter pylori infection, diet (especially high salt and smoked/preserved foods), obesity, smoking, and family history of stomach cancer. Preventing the invisible threat Screen-and-treat programs: The study highlights that national initiatives to screen for and eradicate H. pylori could reduce new stomach cancer cases by up to 75%. Eradication has already reduced gastric cancer risk by roughly 75% in treated populations. Effective treatment protocols: Current treatment involves two weeks of quadruple therapy: two antibiotics, a PPI, plus possibly bismuth. However, rising antibiotic resistance often requires multiple courses. Early detection boosts survival: In the US, early cancer diagnosis rates rose by 53% (2004–2021), improving survival to around 75% – compared to just 7% for late-stage detection. In regions with high H. pylori prevalence, targeted screening via endoscopy and breath/stool tests starting from age 40–50 is recommended. New study finds better treatment for Parkinson's disease
